Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells

Microbial Cell Factories

Volumn 11, Issue , 2012, Pages

  Liovic, Mirjana ^a   Ozir, Mateja ^a   Zavec, Apolonija B ^b   Peternel, Spela ^a,b   Komel, Radovan ^a   Zupancic, Tina ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

Author keywords

E. coli; Electroporation; Inclusion bodies; Intermediate filaments; Keratin; Skin; Therapy

Indexed keywords

COMPLEMENTARY DNA; CYTOKERATIN 14; CYTOKERATIN 5; HETERODIMER; PLASMID DNA; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; CELL GROWTH; CELL INCLUSION; CONTROLLED STUDY; ELECTROPORATION; EPITHELIUM CELL; ESCHERICHIA COLI; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN SECRETION;

DRUG DELIVERY SYSTEMS; ELECTROPORATION; EPITHELIAL CELLS; ESCHERICHIA COLI; HUMANS; INCLUSION BODIES; INTERMEDIATE FILAMENTS; KERATIN-14; KERATIN-5; PROTEIN TRANSPORT; RECOMBINANT PROTEINS;

EID: 84861335612     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-11-67     Document Type: Article

References (30)

1. Martinez-Alonso M, Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact 2009, 8:4. 10.1186/1475-2859-8-4, 2630952, 19133126.
2. Tokatlidis K, Dhurjati P, Millet J, Beguin P, Aubert JP. High activity of inclusion bodies formed in Escherichia coli overproducing Clostridium thermocellum endoglucanase D. FEBS Lett 1991, 282:205-208. 10.1016/0014-5793(91)80478-L, 2026260.
3. Worrall DM, Goss NH. The formation of biologically active beta-galactosidase inclusion bodies in Escherichia coli. Aust J Biotechnol 1989, 3:28-32.
4. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz RM, Aris A, Ventura S, Villaverde A. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact 2005, 4:27. 10.1186/1475-2859-4-27, 1224866, 16156893.
5. Jevsevar S, Gaberc-Porekar V, Fonda I, Podobnik B, Grdadolnik J, Menart V. Production of nonclassical inclusion bodies from which correctly folded protein can be extracted. Biotechnol Prog 2005, 21:632-639.
6. Vera A, Gonzalez-Montalban N, Aris A, Villaverde A. The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures. Biotechnol Bioeng 2007, 96:1101-1106. 10.1002/bit.21218, 17013944.
7. Garcia-Fruitos E, Aris A, Villaverde A. Localization of functional polypeptides in bacterial inclusion bodies. Appl Environ Microbiol 2007, 73:289-294. 10.1128/AEM.01952-06, 1797118, 17085715.
8. Garcia-Fruitos E, Martinez-Alonso M, Gonzalez-Montalban N, Valli M, Mattanovich D, Villaverde A. Divergent genetic control of protein solubility and conformational quality in Escherichia coli. J Mol Biol 2007, 374:195-205. 10.1016/j.jmb.2007.09.004, 17920630.
9. Garcia-Fruitos E, Rodriguez-Carmona E, Diez-Gil C, Ferraz RM, Vazquez E, Corchero JL, Cano-Sarabia M, Ratera I, Ventosa N, Veciana J, Villaverde A. Surface Cell Growth Engineering Assisted by a Novel Bacterial Nanomaterial. Adv Mater 2009, 21:4249.
10. Garcia-Fruitos E, Seras-Franzoso J, Vazquez E, Villaverde A. Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology 2010, 21:205101. 10.1088/0957-4484/21/20/205101, 20413834.
11. Díez-Gil C, Krabbenborg S, Garcia-Fruitos E, Vazquez E, Rodriguez-Carmona E, Ratera I, Ventosa N, Seras-Franzoso J, Cano-Garrido O, Ferrer-Miralles N, Villaverde A, Veciana J. The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials 2010, 31:5805-5812. 10.1016/j.biomaterials.2010.04.008, 20452667.
12. Martinez-Alonso M, Garcia-Fruitos E, Villaverde A. Yield, solubility and conformational quality of soluble proteins are not simultaneously favored in recombinant Escherichia coli. Biotechnol Bioeng 2008, 101:1353-1358. 10.1002/bit.21996, 18980180.
13. Martinez-Alonso M, Vera A, Villaverde A. Role of the chaperone DnaK in protein solubility and conformational quality in inclusion body-forming Escherichia coli cells. FEMS Microbiol Lett 2007, 273:187-195. 10.1111/j.1574-6968.2007.00788.x, 17561947.
14. de Groot NS, Ventura S. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates. J Biotechnol 2006, 125:110-113. 10.1016/j.jbiotec.2006.02.026, 16621081.
15. de Groot NS, Ventura S. Effect of temperature on protein quality in bacterial inclusion bodies. FEBS Lett 2006, 580:6471-6476. 10.1016/j.febslet.2006.10.071, 17101131.
16. Peternel S, Gaberc-Porekar V, Komel R. Bacterial Growth Conditions Affect Quality of GFP Expressed Inside Inclusion Bodies. Acta Chim Slov 2009, 56:860-867.
17. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for non-denaturing extraction of functional proteins. Microb Cell Fact 2008, 7:34. 10.1186/1475-2859-7-34, 2630956, 19046444.
18. Peternel S, Liovic M. Production of Recombinant Proteins in Bacteria: The Inclusion Bodies Formation and their Use in Biomedicine. Recent Patents on Biomedical Engineering 2010, 3:153-161.
19. Nahalka J, Gemeiner P, Bucko M, Wang PG. Bioenergy beads: a tool for regeneration of ATP/NTP in biocatalytic synthesis. Artif Cells Blood Substit Immobil Biotechnol 2006, 34:515-521. 10.1080/10731190600862886, 16893814.
20. Nahalka J, Nidetzky B. Fusion to a pull-down domain: a novel approach of producing Trigonopsis variabilis D-amino acid oxidase as insoluble enzyme aggregates. Biotechnol Bioeng 2007, 97:454-461. 10.1002/bit.21244, 17089401.
21. Nahalka J, Vikartovska A, Hrabarova E. A crosslinked inclusion body process for sialic acid synthesis. J Biotechnol 2008, 134:146-153. 10.1016/j.jbiotec.2008.01.014, 18313163.
22. Nahalka J, Patoprsty V. Enzymatic synthesis of sialylation substrates powered by a novel polyphosphate kinase (PPK3). Org Biomol Chem 2009, 7:1778-1780. 10.1039/b822549b, 19590770.
23. Nahalka J. Physiological aggregation of maltodextrin phosphorylase from Pyrococcus furiosus and its application in a process of batch starch degradation to alpha-D-glucose-1-phosphate. J Ind Microbiol Biotechnol 2008, 35:219-223. 10.1007/s10295-007-0287-4, 18087736.
24. Vázquez E, Corchero JL, Burgueño JF, Seras-Franzoso J, Kosoy A, Bosser R, Mendoza R, Martínez-Láinez JM, Rinas U, Fernández E, Ruiz-Avila L, García-Fruitós E, Villaverde A. Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. Adv Mater 2012, 24:1742-1747. 10.1002/adma.201104330, 22410789.
25. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 1993, 90:10504-10508. 10.1073/pnas.90.22.10504, 47805, 8248137.
26. Chizmadzhev YA, Indenbom AV, Kuzmin PI, Galichenko SV, Weaver JC, Potts RO. Electrical properties of skin at moderate voltages: contribution of appendageal macropores. Biophys J 1998, 74(2 Pt 1):843-856. 1302564, 9533696.
27. Ilic L, Gowrishankar TR, Vaughan TE, Herndon TO, Weaver JC. Microfabrication of individual 200 microm diameter transdermal microconduits using high voltage pulsing in salicylic acid and benzoic acid. J Invest Dermatol 2001, 116:40-49. 10.1046/j.1523-1747.2001.00214.x, 11168796.
28. Zweers JC, Barák I, Becher D, Driessen AJ, Hecker M, Kontinen VP, Saller MJ, Vavrová L, van Dijl JM. Towards the development of Bacillus subtilis as a cell factory for membrane proteins and protein complexes. Microb Cell Fact 2008, 7:10. 10.1186/1475-2859-7-10, 2323362, 18394159.
29. Joosten V, Lokman C, Hondel CA, Punt PJ. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb Cell Fact 2003, 2:1. 10.1186/1475-2859-2-1, 149433, 12605725.
30. Nakashima N, Mitani Y, Tamura T. Actinomycetes as host cells for production of recombinant proteins. Microb Cell Fact 2005, 4:7. 10.1186/1475-2859-4-7, 1079934, 15788099.